Number Of Lymphoid Cells Research Articles

Oral exposure to high concentrations of polystyrene microplastics alters the intestinal environment and metabolic outcomes in mice.

Oral exposure to microplastics (MPs) is a global health concern. In our previous study, MPs induced glucose intolerance and non-alcoholic fatty liver disease (NAFLD) under a high-fat diet-induced leaky gut syndrome (LGS). This study aims to evaluate the effects of high concentrations of MP on lipid metabolism under normal dietary conditions and to assess the changes in the intestinal tract resulting from MP exposure. C57BL6/J mice were fed a normal diet (ND) without polystyrene MPs (PS-MPs) or with PS-MPs (1000 µg/L or 5000 µg/L) for six weeks. Subsequently, intestinal permeability, gut microbiota, and metabolite levels in the serum, feces, and liver were determined. Mice fed the ND showed no increase in intestinal permeability in either group. However, high MPs concentrations led to increased serum lipid levels and exacerbated fatty liver function. Oral exposure to MPs did not affect the number of innate lymphoid cells or short-chain fatty acids in the intestine. However, it increased the number of natural killer cells, altered the gut microbiota, induced inflammation, and modulated the expression of genes related to nutrient transport in the intestine. The severity of intestinal disturbance tended to worsen with dose. Despite the absence of LGS, high concentrations of MPs induced dyslipidemia and NAFLD. Oral exposure to MPs triggered intestinal inflammation via natural killer cells, altered the gut microbiota, and modulated nutrient metabolism. Our study highlights the need for environmental measures to reduce oral MPs exposure in the future.

Role of physicochemical properties in silica nanoparticle-mediated immunostimulation

Immunostimulation caused by nanoparticles may be beneficial or adverse depending on their intended application. Activation of immune cells is beneficial for indications targeting the immune system for therapeutic purposes, such as tumor microenvironment reprogramming, immunotherapy, and vaccines. When it is unwanted, however, immunostimulation may lead to excessive inflammation, cytokine storm, and hypersensitivity reactions. The increasing use of silica nanoparticles (SiNPs) for the delivery of drugs, imaging agents, and antigens warrants preclinical studies aimed at understanding carrier-mediated effects on the number, activation status, and function of immune cell subsets. Herein, we present an in vitro study utilizing primary human peripheral blood mononuclear cells (PBMC) to investigate the proinflammatory properties of four types of SiNPs varying in size and porosity. Cytokine analysis was performed in resting and LPS-primed PBMC cultures to understand the ability of silica nanoparticles to induce de novo and exaggerate preexisting inflammation, respectively. Changes in the number and activation status of lymphoid and myeloid cells were studied by flow cytometry to gain further insight into SiNP-mediated immunostimulation. Nonporous SiNPs were found to be more proinflammatory than mesoporous SiNPs, and larger-sized particles induced greater cytokine response. LPS-primed PBMC resulted in increased susceptibility to SiNPs. Immunophenotyping analysis of SiNP-treated PBMC resulted in T and B lymphocyte, natural killer cell, and dendritic cell activation. Additionally, a loss of regulatory T cells and an increase in γδ TCR T cell population were observed with all particles. These findings have implications for the utility of SiNPs for the delivery of drugs and imaging agents.

Effect of radiochemotherapy on peripheral immune response in glioblastoma

BackgroundGlioblastoma (GBM) is a primary brain tumor with a dismal prognosis, often resistant to immunotherapy and associated with immune suppression. This study aimed to assess the impact of steroids and Stupp-regimen treatment on peripheral blood immune parameters in GBM patients and their association with outcomes.MethodsUsing cytometry panels and bioplex assays, we analyzed the immune phenotype and serum cytokines of 54 GBM patients and 21 healthy volunteers.ResultsGBM patients exhibited decreased lymphoid cell numbers (CD4, CD8 T cells, NKT cells) with heightened immune checkpoint expression and increased myeloid cell numbers (especially neutrophils), along with elevated pro-inflammatory cytokine levels. Steroid use decreased T and NK cell numbers, while radio-chemotherapy led to decreased lymphoid cell numbers, increased myeloid cell numbers, and heightened immune checkpoint expression. Certain immune cell subsets were identified as potential outcome predictors.ConclusionOverall, these findings shed light on the peripheral immune landscape in GBM, emphasizing the immunosuppressive effects of treatment. Baseline immune parameters may serve as prognostic indicators for treatment response.

Developmental characteristics of aggregated lymphoid nodules area in the abomasum of fetal Bactrian camels (Camelus bactrianus)

BackgroundBactrian camel is one of the important economic animals in northwest China. They live in arid desert, and their gestation period is about 13 months, which is longer than other ruminants (such as cattle and sheep). The harsh living conditions have made its unique histological characteristics a research focus. Aggregated lymphoid nodules area (ALNA) in the abomasum of Bactrian camels, as one of the most important sites for the induction of the immune response, provide a comprehensive and effective protective role for the organism, and their lack of information will affect the feeding management, reproduction and epidemic prevention of Bactrian camels. In this study, the histological characteristics of the fetal ALNA in the abomasum of Bactrian camels at different developmental gestation have been described by using light microscopy and histology .ResultsThe ALNA in the abomasum of the Chinese Alashan Bactrian camel is a special immune structure that was first discovered and reported by Wen-hui Wang. To further establish the developmental characteristics of this special structure in the embryonic stage, the abomasum ALNA of 8 fetuses of Alashan Bactrian camels with different gestational ages (5~13 months) were observed and studied by anatomy and histology. The results showed that the aggregation of reticular epithelial cells (RECs) surrounded by a very small number of lymphoid cells was detected for the first time in the abomasum of fetal camel at 5 months gestation, which was presumed to be primitive ALNA. At 7 months gestation, the reticular mucosal folds region (RMFR) appeared, but the longitudinal mucosal folds region (LMFR) was not significant, and histological observations showed that there were diffusely distributed lymphocytes around the RECs. At 10months gestation, RMFR and LMFR were clearly visible, lymphoid follicles appeared in histological observation, lymphocytes proliferated vigorously. By 13 months, the volume of lymphoid follicles increased, forming the subepithelial dome (SED), and there was a primitive interfollicular area between the lymphoid follicles, which contained high endothelial vein (HEV), but no germinal center (GC) was found. In summary, ALNA of Bactrian camels is not fully mature before birth.ConclusionsGenerally, the small intestine PPs of ruminants (such as cattle and sheep) is already mature before birth, while the ALNA in the abomasum of Bactrian camels is not yet mature in the fetal period. During the development of ALNA in Bactrian camel, the development of lymphoid follicles extends from submucosa to Lamina propria. Interestingly, the deformation of FAE changes with age from simple columnar epithelium at the beginning of pregnancy to Simple cuboidal epithelium, which is opposite to the FAE deformation characteristics of PPs in the small intestine of fetal cattle and sheep. These results are the basis of further research on the specificity of ALNA in the abomasum of Bactrian camels.

Enrichment of type 1 innate lymphoid cells in the course of human atherosclerotic plaque development suggests contribution to atherogenesis.

Innate lymphoid cells (ILCs) have been implicated in multiple pathologic conditions, including atherogenesis, as documented in experimental mice studies, however, their role in atherosclerosis in humans remains unexplored. Here, we identify ILCs and their dynamics in early, advanced, and complicated human carotid- and aortic atherosclerotic plaques, using a multiplex immunohistochemical quadruple-staining technique with prototypic transcription factors T-bet, GATA3, or RORgt for identification of the ILC1, ILC2 and ILC3 subsets, respectively, in combination with lineage markers CD3, CD20/ CD79a and CD56 to exclude other lymphoid cell types. ILC subsets were quantified, and to put this in perspective, their numbers were expressed as percentage of the total number of infiltrated lymphoid cells and related to the frequency of conventional T cells, B cells, NK cells, and NKT cells. All ILC subsets were present in every different stage of atherogenesis. ILC1s were the most abundant ILC subset, and their numbers significantly increased in the course of plaque development, but paradoxically, their relative frequency was reduced because of a higher increment of T cells and B cells. The numbers of ILC2s and ILC3s also gradually increased, but this trend did not achieve significance. T cell subsets always significantly outnumbered their ILC counterparts, except for the early lesions where the proportion of ILC1s was markedly higher, albeit not significant. The high abundance of ILC1s in the early stages and further significant enrichment in later stages, suggest they may participate in the initiation and development of atherogenesis, and thus, may represent a novel target to prevent or treat atherosclerosis.

Architectonics of parenchymal organs of white rats under conditions of induced immunosuppression and the use of Interferon lambda

Violation of the functioning of the organs of the immune system, both in humans and in animals, is due to the influence of unfavorable factors of natural and anthropogenic origin on the body, as well as infectious diseases of various etiologies. The article discusses changes in the architectonics of parenchymal organs of white laboratory rats after exposure to the drug interferon lambda on the background of cyclophosphamide (CF). It was found that modeling of immunosuppression through the use of CF led to a decrease in the number of lymphoid cells and the appearance of foci of accumulation of blast cells and megakaryocytes, which indicates a lesion of lymphoid and hematopoietic tissues. In addition, an immunosuppressive effect on the spleen was revealed, the mass coefficient of which in the group with the use of CF was increased 3.53 times, in the group with the simultaneous use of CF and the drug interferon lambda – 2.75 times relative to the control group. There was also a decrease in the mass coefficient of the thymus by 47.6-50.0% in the same groups, which can be regarded as damage to the organs of the immune system. The negative effect of CF on the spleen was confirmed by histological examination. Thus, when inducing immunosuppression, the loss of white pulp was 73.0-77.5% relative to the group of control animals, which is 20.0% higher than in rats treated with interferon lambda, which may indicate a positive immunotropic effect of the drug under study. In addition, no significant morphological changes were detected when the body of healthy rats was exposed to interferon lambda in the studied organs, the morphological picture is similar to that of intact animals, which may indicate the safety of its use to animals.

Lithium impacts the function of hematopoietic stem cells via disturbing the endoplasmic reticulum stress and Hsp90 signaling

Lithium (Li) has been widely used in clinical therapy and new Li-ion battery industry. To date, the impact of Li on the development of immune cells is largely unknown. The aim of this study was to investigate the impact of Li on hematopoiesis. C57BL/6 (B6) mice were treated with 50 ppm LiCl, 200 ppm LiCl, or the control via drinking water for 3 months, and thereafter the hematopoiesis was evaluated. Treatment with Li increased the number of mature lymphoid cells while suppressing the number of mature myeloid cells in mice. In addition, a direct action of Li on hematopoietic stem cells (HSC) suppressed endoplasmic reticulum (ER) stress to reduce the proliferation of HSC in the bone marrow (BM), thus leading to fewer HSC in mice. On the other hand, the suppression of ER stress by Li exposure increased the expression of Hsp90, which promoted the potential of lymphopoiesis but did not impact that for myelopoiesis in HSC in the BM of mice. Moreover, in vitro treatment with Li also likely disturbed the ER stress-Hsp90 signaling, suppressed the proliferation, and increased the potential for lymphopoiesis in human HSC. Our study reveals a previously unrecognized toxicity of Li on HSC and may advance our understanding for the immunotoxicology of Li.

Effect of Boric Acid on Oxidative Damage in Immunocompetent Organs under Conditions of Potassium Bichromate and Gamma Radiation Exposure

The immune system supports antigenic homeostasis in the body and regulates the processes of proliferation and differentiation of cellular components in hemo- and immunopoiesis. Chromium compounds and ionizing radiation lead to the formation of highly reactive free radicals. Sublethal dose of gamma-irradiation is characterized by a 56% decrease in thymus cellularity and a 22% decrease in lymph nodes against the background of a 44% increase in the number of lymphoid cells in the spleen. Under the combined effect of hexavalent chromium and gamma-radiation, a decrease in the number of lymphoid cells is observed. In thymus the cellularity decreases by 70%, in spleen - by 40%, in lymph nodes - by 42% in comparison with control data. Under the influence of boric acid the number of lymphoid cells in thymus significantly increases by 47%, in lymph nodes - by 14% (p<0.05) compared to the data of irradiated animals. Boric acid administration weakens the development of oxidative stress, lipid peroxidation decreases, and the activity of antioxidant defense enzymes in immunocompetent cells is increased.

Primary CNS EBV-positive post-transplant lymphoproliferative disorder with polymorphic and classic Hodgkin lymphoma features: A case report and literature review.

Post-transplant lymphoproliferative disorders (PTLD) are typically Epstein-Barr virus (EBV)-associated lymphoid or plasmacytic proliferations that occur when immunosuppressed after transplantation. Only 2 cases of primary central nervous system (PCNS) classic Hodgkin lymphoma PTLD and 1 case of PCNS Hodgkin lymphoma-like PTLD have been previously reported. A 59-year-old male presented with malaise, headaches, and dizziness; neuroimaging revealed a 1.7-cm right cerebellar mass and a 0.6-cm right frontal mass. Microscopic examination demonstrated a perivascular and parenchymal polymorphous infiltrate composed of lymphocytes (CD3-positive T cells and CD20-positive B cells), plasma cells, and macrophages. Focally, macrophages had a spindled morphology with a fascicular arrangement amounting to poorly formed granulomata. Mitoses were seen. Scattered large atypical cells were visualized with irregular hyperchromatic nuclei, reminiscent of lacunar cells, mononuclear Hodgkin and binucleate Reed-Sternberg (RS) cells. EBV in situ highlighted a significant number of small lymphoid cells as well as many large atypical forms. Large atypical cells were seen to co-express CD15 and CD30. To our knowledge, this is the first such case with hybrid polymorphic PTLD and classic Hodgkin lymphoma features and the first such case to arise following liver transplantation. This case highlights the histological and immunophenotypic spectrum of these lymphoid proliferations and the resulting challenges in diagnosis and definitive subtyping.

The Bruton’s Tyrosine Kinase Inhibitor Evobrutinib Demonstrates Superior Efficacy in Targeting Compartmentalized Neuroinflammation Compared to Anti-CD20 Treatment. (S16.004)

<h3>Objective:</h3> To evaluate the efficacy of evobrutinib, a central nervous system (CNS)-penetrant Bruton’s tyrosine kinase inhibitor (BTKi), versus anti-CD20 treatment, on compartmentalized neuroinflammation and disease outcomes in a novel mouse model recapitulating key features of disease progression in multiple sclerosis (MS). <h3>Background:</h3> In MS, compartmentalized neuroinflammation often starts early and is characterized by an accumulation of persistent B cell rich aggregates. Compartmentalized neuroinflammation is predictive of both poor clinical outcomes and rapid disability progression. B cells within the CNS may be protected from established MS therapies such as anti-CD20 antibodies. CNS-penetrant small molecules directed against BTK – with its critical role in B cell activation, proliferation, and survival – have emerged to potentially target chronic neuroinflammation. <h3>Design/Methods:</h3> Preclinical assessments compared the therapeutic potential of evobrutinib and anti-CD20 antibodies on MS progression using the experimental autoimmune encephalomyelitis mouse model with features of progression (pEAE). Clinical outcomes and their correlation with CNS immunopathological parameters were assessed in pEAE mice to recapitulate key aspects of MS disease progression. <h3>Results:</h3> Evobrutinib, versus anti-CD20 (clone: SA271G2) treatment, reduced disease severity (65% reduction; P&lt;0.0001) and immunopathological parameters of disease (56% reduction; P&lt;0.01) in pEAE mice. The beneficial effects of BTKi were paralleled by body-weight gain and a decrease in maximum disease score versus anti-CD20 treatment. Evobrutinib lessened neuroinflammation by significantly reducing the number and activation of lymphoid and myeloid cells as well as the extent of submeningeal demyelination both in the brain (44% reduction; P&lt;0.01) and the spinal cord (42% reduction; P&lt;0.01). <h3>Conclusions:</h3> The improvements in clinical, immunological, and neuropathological parameters of disease observed in pEAE mice treated with evobrutinib illustrate the importance of compartmentalized neuroinflammation for disease progression. The limited effect of anti-CD20 treatment confirms the insufficient disease inhibition potential of antibody-based therapies when targeting intrathecal B cells. These findings support the notion that evobrutinib targets persistent neuroinflammation in MS. <b>Disclosure:</b> Ms. Kebir has received research support from Fonds de Recherche du Québec-Santé. Ms. Kebir has received intellectual property interests from a discovery or technology relating to health care. Cen Li has received research support from Chinese Scholarship Council. The institution of Michael May has received research support from NIH. Molly Church has nothing to disclose. Ursula Boschert has nothing to disclose. Jorge Alvarez has nothing to disclose.

Comprehensive landscape of immune-based classifier related to early diagnosis and macrophage M1 in spinal cord injury.

Numerous studies have documented that immune responses are crucial in the pathophysiology of spinal cord injury (SCI). Our study aimed to uncover the function of immune-related genes (IRGs) in SCI. Here, we comprehensively evaluated the transcriptome data of SCI and healthy controls (HC) obtained from the GEO Database integrating bioinformatics and experiments. First, a total of 2067 DEGs were identified between the SCI and HC groups. Functional enrichment analysis revealed substantial immune-related pathways and functions that were abnormally activated in the SCI group. Immune analysis revealed that myeloid immune cells were predominantly upregulated in SCI patients, while a large number of lymphoid immune cells were dramatically downregulated. Subsequently, 51 major IRGs were screened as key genes involved in SCI based on the intersection of the results of WGCNA analysis, DEGs, and IRGs. Based on the expression profiles of these genes, two distinct immune modulation patterns were recognized exhibiting opposite immune characteristics. Moreover, 2 core IRGs (FCER1G and NFATC2) were determined to accurately predict the occurrence of SCI via machine learning. qPCR analysis was used to validate the expression of core IRGs in an external independent cohort. Finally, the expression of these core IRGs was validated by sequencing, WB, and IF analysis in vivo. We found that these two core IRGs were closely associated with immune cells and verified the co-localization of FCER1G with macrophage M1 via IF analysis. Our study revealed the key role of immune-related genes in SCI and contributed to a fresh perspective for early diagnosis and treatment of SCI.

English

Strychnos camptoneura (Loganiaceae) is used in Congolese traditional medicine to treat various diseases such as malaria and diabetes, but not much is known about its effects on the immune system. Therefore, the purpose of this study was to investigate the immunomodulatory properties of S. camptoneura leaves. Mice were treated with the aqueous extract of S. camptoneura leaves (100 and 200 mg/kg); those administered with reverse osmosis water and &beta;-1,3-glucan (150 mg/kg) were used as negative and positive controls, respectively. The immunomodulatory effects were measured 24 h post-treatment by quantifying the production of cytokines, and the number of myeloid and lymphoid cells. Treated mice with the aqueous extract showed a significant production of IL-4 and IL-10 compared to negative animals (P &lt;0.001). Similar to &beta;-1,3-glucan, both doses of aqueous extract markedly increased the number of macrophages, dendritic cells, CD4+ T and NK cells in treated-mice, but not of CD8+T cells. These findings suggest that the S. camptoneura leaves possess immunomodulatory properties. Further studies are needed to determine phytochemicals in these leaves and signaling pathways involved in the immunomodulation. This would help to better understand and valorize the therapeutic potential of S. camptoneura. Key words: Strychnos camptoneura, immunomodulatory effects, cytokines, myeloid cells, lymphoid cells, mice.

Lymphoma of the urinary bladder with concomitant septic peritonitis in a dog

AbstractA 6‐year‐old, female, neutered German shepherd dog presented with an acute history of stranguria and pollakiuria. The dog was depressed but the remainder of the examination was unremarkable. Urine cytology revealed severe bacteriuria and pyuria, suggesting urinary tract infection, and a low number of large atypical lymphoid cells. Abdominal ultrasound revealed the presence of diffuse thickening of the urinary bladder wall in the area of the trigone, enlargement of the left medial iliac lymph node and a large volume of peritoneal effusion. Cytology of the lymph node confirmed large cell lymphoma, and cytology of the abdominal effusion revealed septic neutrophilic inflammation. Urinary bladder lymphoma and septic peritonitis were diagnosed, and euthanasia was elected. Full gross and histopathological postmortem examination concluded the presence of a primary urinary bladder B‐cell lymphoma. No definitive cause of the septic peritonitis could be established, but bacterial translocation from the urinary bladder was suspected.

Ribonuclease Inhibitor 1 (RNH1) Regulates Myeloid Lineage Choice through Cyclin-Dependent Kinase 1

Background: Myelopoiesis is a complex process, it begins with myeloid lineage choice determination in haemopoietic stem cells (HSCs). Still we do not have complete molecular understanding of how myeloid lineage choices were determined. Although transcription factors expression majorly determine the lineage choices at HSCs level, recent study suggest that ratios of total PU.1:GATA1 protein levels are not the central mechanism that initiates HSPC lineage decisions . Further, cell fate commitment is linked to the cell cycle regulation, however whether the cell cycle itself regulates lineage choices in HSCs is not known. Previously, we have published that Ribonuclease inhibitor (RNH1) deletion in mice leads to defect inembryonic erythropoiesis. Here, we report that RNH1 regulates myeloid lineage choice through cyclin-dependent kinase 1 (CDK1) mediated cell cycle regulation. Methods: We have generated hematopoietic-specific conditional knockout mice by crossing Rnh1FL/FL mice with Vav1-iCre and Mx1-Cre mice, respectively. Phenotypic analysis, Bone marrow transplantation (BMT) experiments, cell cycle and CFU assays were performed. To understand molecular mechanism RNA seq, mass spectrometry, confocal microscopy and biochemical studies were performed. Histopathology performed in AML bone marrow biopsies. RNH1 was knocked out in several AML cell lines and analyzed myeloid differentiation and performed CFU assays. Results: Rnh1-deficiency in both Vav1-iCre and Mx1-Cre models resulted in elevated levels of myeloid cells but decreased lymphoid cells and haemoglobin (HGB) levels in peripheral blood. Total bone-marrow (BM) cellularity was similar in wild type (WT) and Rnh1-/- mice. However, the number of erythroid cells and lymphoid cells was significantly decreased, whereas myeloid cells were significantly increased. We analysed the progenitor populations in the BM. In line with increased myelopoiesis phenotype, granulocyte-monocyte progenitor (GMP) cell numbers were increased but common lymphoid progenitor (CLP) and megakaryocyte-erythrocyte progenitor (MEP) cell numbers were decreased. Interestingly, we found increased numbers of long term HSCs (LT-HSCs) and short term HSCs (ST-HSCs) in Rnh1-/- mouse BM, suggesting that RNH1 could affect HSC function. Supporting this, Rnh1-/- HSCs failed to engraft lethally irradiated mice in competitive and non- competitive BMT experiments. Intriguingly, despite increased myelopoiesis in Rnh1-/- mice, conventional myeloid genes that support myelopoiesis were not increased in Rnh1-/- HSCs by RNA-Seq studies. Rather we found increased expression of genes related to cell cycle, kinetochore and DNA damage in Rnh1-/- HSCs. Corroborating this, Rnh1-/- HSCs showed significant increase in G1 cycle phase compared to WT. At the molecular level, we found that RNH1 directly binds to CDK1 and also inhibits CDK1 kinase function. Supporting this, molecular docking studies suggest that RNH1 potentially binds with CDK1. In agreement with this, loss of RNH1 in HSCs increased CDK1 protein levels as well as increased CDK1 phosphorylation at Thr161. Further, CDK1 inhibitor treatment decreased myelopoiesis and rescued erythropoiesis and lymphopoiesis in Rnh1-/- mice. We checked whether RNH1 mediated myelopoiesis is relevant in any disease models and can be targeted. Interestingly, we found increased RNH1 expression in AML patients bone marrow biopsies independent of their genetic mutation. AML blasts have myeloid differentiation arrest and therapies that resolve differentiation arrest represent a powerful treatment strategy. Interestingly, RNH1 deletion in AML cell lines leads to increased expression of the myeloid markers, increased cell death and formed less colonies compared to wild type cells. Summary: Collectively, our studies suggest that loss of RNH1 in HSCs leads to dysregulation in cell cycle through increased CDK1 activity. Dysregulation in cell cycle decreases HSCs stemness and repopulating potential, and influences cell fate decisions by increasing myelopoiesis. Since loss of RNH1 increased myelopoiesis without increase of myeloid transcription factors expression and dependent on CDK1, we call this pathway 'alternative myelopoiesis'. Targeting alternative myelopoiesis could be a potential therapy for AML.

DDB1 and CUL4 Associated Factor 7 (DCAF7) Is Essential for Hematopoiesis

Mutations in DDB1 And CUL4 Associated Factor 7 (DCAF7) have been detected in a subset of patients with Myeloid Leukemia in Down syndrome. DCAF7 is a highly conserved WD40 domain protein with 100% homology among vertebrates and is a prominent binding partner of DYRK1A, a kinase located on chromosome 21. Analysis of the DepMap database revealed that hematopoietic cell lines are highly dependent on DCAF7 compared to cell lines from other tumors. However, the function of DCAF7 during normal hematopoiesis is currently unknown. Thus, we aimed to study its function in hematopoietic cell lines and in a conditional knockout mouse model. We first deleted DCAF7 from a panel of hematopoietic cell lines by CRISPR/Cas9 editing and observed its absence led to cell cycle arrest and decreased proliferation. Rescue experiments in which a CRISPR resistant DCAF7 allele was expressed in the targeted clones restored proliferation and cell cycling. A comparison of RNA-seq data between parental HEL cells and those without DCAF7 showed decreased expression of genes involved in differentiation, TNF signaling and the IFN pathway, indicating that DCAF7 is important for cell differentiation. Next, we created a Dcaf7 conditionally targeted mouse strain (Dcaf7F/F Mx-1 Cre) and assessed its role in hematopoiesis in vivo. Following Cre induction by pIpC, we observed a decrease in white blood cells, hemoglobin and platelet counts in KO mice. Analysis of the bone marrow showed an accumulation of LT-HSCs and multipotent progenitors. In addition, we observed a defect in the generation of B-cells, reminiscent of the phenotype observed upon Dyr1ka deletion. We then tested the recovery of Dcaf7 KO hematopoietic cells after different types of stress, which included ex-vivo culture, transplantation, and myelosuppression. Dcaf7 deficient HSCs showed defective expansion in PVA-containing media and poor differentiation in single cell colony assays in methylcellulose. In non-competitive transplants, KO cells reconstituted hematopoiesis although the number of mature myeloid and lymphoid cells was dramatically decreased. In competitive transplants, Dcaf7 KO cells were outcompeted by wild-type cells. Lastly, upon myelosuppression with 5-FU, Dcaf7 deficient mice were not able to recover and died acutely. Overall, these results indicate that DCAF7 plays a critical role in HSCs during homeostasis and regeneration. To uncover the mechanisms by which DCAF7 contributes to hematopoiesis, we performed IP-MS using tagged DCAF7 as bait in a hematopoietic cell line. In addition to DYRK1A, we found that DCAF7 interacts with multiple components of the polycomb repressive complex1 (PRC1), specifically the non-canonical PRC1.5 complex, which has been previously implicated in gene activation and transcription. We confirmed that DCAF7 engages in the PRC1.5 complex by glycerol gradient centrifugation. Upon DCAF7 absence the size the PRC1 complex shifts towards a lower molecular weight, indicating that DCAF7 is a core subunit of the complex. We then performed RNASeq analysis in sorted LT-HSCs (Lin-cKit+Sca1+CD48-CD150+) and found that 70% of the differentially expressed genes were downregulated in KO cells. These downregulated genes were associated with diminished activation of GATA1, GATA2, RUNX1 and SP1 target genes, in agreement with the functional role of the PRC1.5 complex in gene activation and cell differentiation. Together our results reveal that DCAF7 regulates hematopoiesis by participating in transcriptional regulatory complexes, and we predict that DCAF7 mutations contribute to leukemia by cooperating with DYRK1A and altering the activity of the PRC1 complex.

Macro-microscopic features of the structure of lymphoid nodules in the wall of the female urethra

The aim of the investigation was to study the macro-microscopic features of the structure and quantitative indicators of the lymphoid nodules of the female urethra in postnatal ontogenesis.Material and methods. The topography, number and size of lymphoid nodules in the urethral wall from corpses of 63 women of different age groups were studied by macro-microscopy using binocular stereomicroscope MBS-9 after elective staining with Harris hematoxylin. The material was fixed in a 10% formalin solution. The preparations were photographed and the area of lymphoid nodules was measured in the ImageJ program. For statistical data processing, parametric statistics methods based on the Statistica 6.0 program were used. Statistical data processing included the calculation of arithmetic averages, their errors, and the analysis of the amplitude of the variation series of each indicator.Results. The maximum number of lymphoid nodules in the urethra in early childhood corresponds to the idea of the largest total number of lymphoid cells, the severity of lymphoid tissue in the first years of life. The density of lymphoid nodules is maximum in the 1st period of childhood (9,5–10,5 nodules), and then decreases sequentially. In senile age, compared with the 1st period of childhood, the density of localization of lymphoid nodules decreases in the walls of the upper third of the urethra by 1.7 times (p&lt; 0.05), the middle and lower thirds of the organ - by 1.2 times (p&lt;0.05) and the urethra as a whole – by 1.3 times (p&lt;0.05). The amplitude of the variation series (differences between individual maximum and minimum) of the density of the location of lymphoid nodules, according to our data, does not change significantly during postnatal ontogenesis. The size of the lymphoid nodule during postnatal ontogenesis is maximal in the 1st period of childhood. Further, the value of this indicator decreases and reaches a minimum in old age and in centenarians.Conclusion. The study showed that lymphoid tissue in the urethral wall is at different stages of morphogenetic maturity, lymphoid nodules are found, which, as is known, are considered to be a more functionally mature stage of lymphoid tissue development. The values of the density of the location of lymphoid nodules throughout the female urethra in postnatal ontogenesis change slightly, the minimum number of them is observed in old age and the period of longevity, the maximum does not actually change.

Activation of CD81+ skin ILC2s by cold-sensing TRPM8+ neuron-derived signals maintains cutaneous thermal homeostasis.

As the outermost barrier tissue of the body, the skin harbors a large number of innate lymphoid cells (ILCs) that help maintain local homeostasis in the face of changing environments. How skin-resident ILCs are regulated and function in local homeostatic maintenance is poorly understood. We here report the discovery of a cold-sensing neuron-initiated pathway that activates skin group 2 ILCs (ILC2s) to help maintain thermal homeostasis. In stearoyl-CoA desaturase 1 (SCD1) knockout mice whose skin is defective in heat maintenance, chronic cold stress induced excessive activation of CCR10-CD81+ST2+ skin ILC2s and associated inflammation. Mechanistically, stimulation of the cold-sensing receptor TRPM8 expressed in sensory neurons of the skin led to increased production of IL-18, which, in turn, activated skin ILC2s to promote thermogenesis. Our findings reveal a neuroimmune link that regulates activation of skin ILC2s to support thermal homeostasis and promotes skin inflammation after hyperactivation.

Metabolic Syndrome in Psoriasis Is Associated With Upregulation of CXCL16 on Monocytes and a Dysbalance in Innate Lymphoid Cells.

Psoriasis is frequently associated with the metabolic syndrome and occurs more often in obese individuals. In order to understand innate immune mechanisms mediating this inflammatory pattern we investigated expression of the chemokine and lipid scavenger receptor CXCL16 in patients with psoriasis and associated comorbidities. CXCL16 expression was enhanced on all monocyte subsets in psoriatic patients compared with healthy controls and positively correlated with psoriasis activity and severity index, body mass index and the risk for cardiovascular disease indicated by PROCAM score. The intensity of CXCL16 expression on monocytes further correlated with their capability to phagocytose oxidized LDL indicating the possibility to transform into foam cells in atherosclerotic plaques. Patients with psoriasis and atherosclerosis or obesity displayed elevated numbers of innate lymphoid cells in blood with specific increase of the IFN-γ or IL-17 producing ILC1 and ILC3 subpopulations. The expression of the CXCL16 receptor, CXCR6, was increased in ILCs and co-expressed with CCR6 but not CCR7 indicating their migratory potential to psoriatic skin or adipose tissue that is characterized by strong CXCL16 and CCL20 expression. This hypothesis was supported by the finding that the percentage of CXCR6 expressing ILCs was alleviated in blood of psoriatic patients. Together these data link a strong expression of CXCL16 to metabolic syndrome in psoriasis and indicate a possible link to ILC activation and tissue distribution in obese psoriatic patients. These data contribute to the understanding of the complex interaction of innate immunity and metabolic state in psoriasis.

Single‐Cell RNA‐Seq Profiling Identifies L1 Cell Adhesion Molecule (L1cam) as a Mediator in Colonic Tuft Cells ‐ Innate Lymphoid Cell (ILCs) Signaling in the Hnrnp I Knockout Mice

ObjectivesPreviously we found that ablation of heterogeneous nuclear ribonucleoprotein I, (Hnrnp I) in intestinal epithelial cells (IECs) in colon significantly upregulates inflammatory cytokines and chemokines expression and increases number of tuft cells and innate lymphoid cells (ILCs, including ILC1, ILC2 and ILC3) in colon. The objective of this current study is to investigate the cell‐cell communications and to identify the mediators involved in the colon of Hnrnp I knockout (KO) mice. We hypothesize that signal transduction between colonic tuft cells and ILCs stimulates cytokine expression in the knockout mice.MethodsSingle‐cell RNAseq libraries (n = 3) were prepared from total RNA extracted from colon using Chromium Single‐Cell Gene Expression NextGem (v3.1, 10X Genomics). Analyses from raw counts were performed using the Seurat (v3.2.0) R package using default parameters. A computational cell calling algorithm was used to identify cell types using two up‐to‐date annotated mouse cell datasets. Analyses of cell‐cell communications and identification of significant pathways were performed using CellChat (v1.1.3). Immunofluorescence staining of colon tissue was performed with anti‐DCAMKL1 antibody (Abcam, ab31704). Colon cytokine levels were examined using cytokine 32‐plex array (Eve Technologies) using total protein extracted from colon tissues.ResultsImmunofluorescence staining of DCAMKL1, a tuft cell marker, confirms that the number of Tuft cells in colon (normalized to number of crypt) is significantly increased in Hnrnp I KO mice comparing to Hnrnp I wildtype (WT). Results from CellChat suggest communications between tuft cells and immune cells (ILCs, cytotoxic T cells, helper T cells, active lymphocytes and myeloid progenitors) are mainly through L1 Cell Adhesion Molecule (L1cam) – Integrins interaction, which is KO‐specific because the ablation of Hnrnp I results in the expression of L1cam in tuft cells in KO mice. Expression of integrin αv and β3 subunits (Itgav and Itgb3) are also higher in ILCs in the KO mice. NF‐κB subunits P65, and NF‐κB pathway target genes P21 and c‐Myc, also show higher expression levels in ILCs in KO mice comparing to WT. Cytokines assay results show that IL4, IL6 and IL13 all significantly increased, while IFNγ unchanged, and IL17 decreased in colon in KO mice comparing to WT.ConclusionsOur results demonstrate an Hnrnp I KO‐specific communication in colon between tuft cells and ILCs via L1cam‐integrin αv and β3 subunits interaction. The interaction further activates NF‐κB signaling in ILCs, regulating cell cycle of ILCs. The activation of ILCs further triggers immune responses in KO mice as indicated by increased proinflammatory cytokine expressions. Our results also suggest that among ILC1, ILC2 and ILC3, ILC2 is the major cell type involved in this communication because those increased cytokines – IL4, IL6 and IL13 observed in KO mice are all effectors secreted by mature ILC2.

TCDD exposure alters fecal IgA concentrations in male and female mice

BackgroundActivation of the aryl hydrocarbon receptor (AhR) can alter diurnal rhythms including those for innate lymphoid cell numbers, cytokine and hormone levels, and feeding behaviors. Because immune responses and antibody levels are modulated by exposure to AhR agonists, we hypothesized that some of the variation previously reported for the effects of AhR activation on fecal secretory immunoglobulin A (sIgA) levels could be explained by dysregulation of the diurnal sIgA rhythm.MethodsC57Bl/6 J mice were exposed to peanut oil or 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD, 10 or 40 μg/Kg) and fecal sIgA levels were determined in samples collected every 4 h over 4 days.ResultsFecal sIgA concentrations were not significantly different between light and dark phases of the photoperiod in either male or female mice, and there were no significant circadian rhythms observed, but TCDD exposure significantly altered both fecal mesor sIgA and serum IgA concentrations, in parallel, in male (increased) and female (biphasic) mice.ConclusionsAhR activation can contribute to the regulation of steady state IgA/sIgA concentrations.